The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Increase in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 23,400 shares, an increase of 216.2% from the December 15th total of 7,400 shares. Based on an average daily volume of 28,300 shares, the short-interest ratio is presently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Price Performance

Shares of NASDAQ:CGABL opened at $18.44 on Thursday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52 week low of $17.48 and a 52 week high of $20.85. The firm has a fifty day simple moving average of $18.72 and a two-hundred day simple moving average of $19.14.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, February 15th. Shareholders of record on Saturday, February 1st will be paid a $0.2891 dividend. The ex-dividend date of this dividend is Friday, January 31st. This represents a $1.16 annualized dividend and a yield of 6.27%. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.